Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

391
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
391
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

551
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
551
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

566
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
566
Hazard Rate01:11

Hazard Rate

400
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
400
Actuarial Approach01:20

Actuarial Approach

286
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
286
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

745
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
745

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Photoelectrochemically homogeneous nickel oxide photocathode composed of nanocrystals prepared by supercritical hydrothermal synthesis.

Nanoscale advances·2026
Same author

Coexistence of Metal and Dielectric Resonance Modes in a Single Nanostructure of a Hyperbolic Material.

ACS nano·2026
Same author

Plant-derived exosome-like nanoparticles ameliorate glycolipid metabolism diseases: molecular mechanism, advances and bottlenecks.

Food & function·2026
Same author

Privacy-enhancing sequential learning under heterogeneous selection bias in multi-site electronic health records data.

Journal of the American Medical Informatics Association : JAMIA·2026
Same author

Phase Ib/II Study of Preliminary Efficacy, Safety and Pharmacodynamics of MG-K10, a Humanised Monoclonal Antibody Targeting IL-4Rα, in Adult Chinese Patients With Asthma.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author

Longitudinal analyses of depressive symptoms across pregnancy in Black women.

Annals of epidemiology·2026
Same journal

Latent Class Log-Linear Models for Estimating Diagnostic Test Accuracy Without a Gold Standard: A Simulation Study.

Statistics in medicine·2026
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
查看所有相关文章

相关实验视频

Updated: Jan 14, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

523

协作推断加速失效时间模型使用临床中心级总结统计数据.

Mengtong Hu1, Xu Shi1, Ziyang Gong2

  • 1Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, USA.

Statistics in medicine
|October 22, 2025
PubMed
概括
此摘要是机器生成的。

这项研究引入了一个新的框架,用于分析使用加速失效时间 (AFT) 模型的多中心临床试验的生存数据. 这种方法增强了数据集成,并为时间到事件结果提供了更可靠的结果.

关键词:
数据隐私 隐私数据 隐私数据分布的推理推理.这是一个元分析.可再生能源估计可再生能源估计生存分析,生存分析.

更多相关视频

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.5K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K

相关实验视频

Last Updated: Jan 14, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

523
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.5K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K

科学领域:

  • 生物统计学 生物统计学
  • 临床研究方法论 临床研究方法论
  • 生存分析的分析.

背景情况:

  • 多中心临床研究产生更大的样本大小和更普遍的发现.
  • 现有的生存数据分析方法在多个地点进行综合分析时可能存在局限性.
  • 加速失效时间 (AFT) 模型为时间到事件数据提供了可克斯比例危险模型的替代方案.

研究的目的:

  • 开发一个协作分析框架,使用总结统计数据进行生存数据分析.
  • 实施基于参数加速失效时间 (AFT) 模型的分布式推断方法.
  • 用分布式概率测试来评估不同参数的AFT模型的适用性.

主要方法:

  • 开发了一个协作框架,利用总结统计数据进行生存数据分析.
  • 使用参数 AFT 模型 (韦布尔,日志-正常,日志-逻辑) 来获得时间到事件的结果.
  • 建立了一个分布式概率测试在一般化的马分布下模型评估.

主要成果:

  • 拟议的分布式推理方法表现出强大的性能.
  • 确定了分布式方法的大样本特性.
  • 该框架通过模拟和真实世界移植数据集得到验证.

结论:

  • 开发的框架促进了多中心生存数据的灵活和强大的整合分析.
  • AFT模型和分布式推理方法比传统的多地点研究方法具有优势.
  • 这种方法提高了协作临床研究结果的可靠性和通用性.